Esomeprazole News and Research

RSS
Esomeprazole is a drug that blocks acid from being made in the stomach. It is used to treat acid reflux disease and to prevent certain types of gastrointestinal ulcers. Esomeprazole magnesium is being studied in the prevention of esophageal cancer and in the treatment of other conditions, including side effects of chemotherapy. It is a type of anti-ulcer agent. Also called esomeprazole and Nexium.
Common medications to treat heartburn linked to increased risks for kidney failure

Common medications to treat heartburn linked to increased risks for kidney failure

Esophageal cancer risk could be reduced by esomeprazole and low dose aspirin

Esophageal cancer risk could be reduced by esomeprazole and low dose aspirin

Study investigates use of drugs for the stomach and risk of major depressive disorder

Study investigates use of drugs for the stomach and risk of major depressive disorder

Proton pump inhibitors linked to increased death risk

Proton pump inhibitors linked to increased death risk

Chronic use of antacid drugs may speed up aging of blood vessels

Chronic use of antacid drugs may speed up aging of blood vessels

Acid suppression drugs frequently prescribed for high-risk newborns, study shows

Acid suppression drugs frequently prescribed for high-risk newborns, study shows

Synthetic Biologics announces positive results from first SYN-004 Phase 2a study for prevention of CDI, AAD

Synthetic Biologics announces positive results from first SYN-004 Phase 2a study for prevention of CDI, AAD

Camber Pharmaceuticals releases generic version of Nexium (Esomeprazole) capsules

Camber Pharmaceuticals releases generic version of Nexium (Esomeprazole) capsules

Mylan announces launch of Esomeprazole Magnesium Delayed-release Capsules USP in U.S.

Mylan announces launch of Esomeprazole Magnesium Delayed-release Capsules USP in U.S.

ViiV Healthcare initiates Phase III trial to evaluate dolutegravir and rilpivirine in HIV patients

ViiV Healthcare initiates Phase III trial to evaluate dolutegravir and rilpivirine in HIV patients

MHRA reclassifies Pfizer’s Nexium Control as an OTC treatment for heartburn

MHRA reclassifies Pfizer’s Nexium Control as an OTC treatment for heartburn

New Mayo Clinic study shows impact of long-term use of proton pump inhibitors

New Mayo Clinic study shows impact of long-term use of proton pump inhibitors

Janssen, Viiv Healthcare to develop single tablet regimen for maintenance treatment of HIV

Janssen, Viiv Healthcare to develop single tablet regimen for maintenance treatment of HIV

Pfizer issues statement on FDA approval of non-prescription drug, Nexium 24HR

Pfizer issues statement on FDA approval of non-prescription drug, Nexium 24HR

Merck's NOXAFIL injection gets FDA approval for intravenous use

Merck's NOXAFIL injection gets FDA approval for intravenous use

POZEN reports total revenue of $4.7 million for fourth quarter 2013

POZEN reports total revenue of $4.7 million for fourth quarter 2013

Erosive GERD treatments: an interview with Professor Joaquim Moraes-Filho, University of São Paulo Medical School

Erosive GERD treatments: an interview with Professor Joaquim Moraes-Filho, University of São Paulo Medical School

Amneal launches generic Esomeprazole strontium delayed-release capsules 49.3 mg

Amneal launches generic Esomeprazole strontium delayed-release capsules 49.3 mg

Amneal's Esomeprazole Strontium 49.3 mg delayed-release capsules now available for GERD patients

Amneal's Esomeprazole Strontium 49.3 mg delayed-release capsules now available for GERD patients

Gilead Sciences gets FDA approval for once-daily single tablet HIV-1 regimen Complera

Gilead Sciences gets FDA approval for once-daily single tablet HIV-1 regimen Complera